Cardiology trials are among the most complex and demanding therapeutic areas in clinical research. Despite high disease prevalence and large patient databases, identifying eligible participants often proves difficult.
Cardiology studies typically face:
- Stringent inclusion and exclusion criteria, narrowing eligibility within already well-screened patient populations.
- Patients with multiple comorbidities or overlapping medications that exclude them from participation.
- Extended follow-up periods and intensive visit schedules that can increase patient and site burden.
- Heavy reliance on busy clinical sites, where limited staff availability can restrict time for database searches and pre-screening activities.
These factors frequently lead to recruitment delays and extended timelines, even for well-established sites.
This was the situation faced by the sponsor of a cardiology rescue study in the United Kingdom. After limited recruitment success across ten sites, the sponsor turned to MRN’s Site Support services to enhance patient identification and accelerate enrollment.
Download the full case study below to learn more.